Immix Biopharma
clinical highlights in single day | Immix Biopharma
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
36 of 64
Similar slides by Immix Biopharma
See diffirences between slides (animation)
Investor Presentation
December 2023
clinical highlights across patients outpatient car potential | Immix Biopharma
Investor Presentation
November 2023
clinical highlights across patients outpatient car potential | Immix Biopharma
Investor Presentation
November 2023
clinical highlights across patients outpatient car potential | Immix Biopharma
Investor Presentation
November 2023
clinical highlights across patients outpatient car potential | Immix Biopharma
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
dare and dare dare i | Dare Bioscience
Recursion Pharmaceuticals
Investor Day
January 2023
clinical patient population large and diagnosable no approved medical therapy disease overview cerebral cavernous malformations | Recursion Pharmaceuticals
Genelux
Investor Presentation
October 2023
clinically meaningful responses in heavily patients rescore a | Genelux
Genelux
Investor Presentation
February 2024
phase clinically meaningful responses in heavily patients | Genelux
Other recent decks by Immix Biopharma
See all presentations (11 decks)
Investor Presentation
March 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights